CBD for Dogs with Anxiety: What the Research Actually Says
CBD for Dogs with Anxiety: What the Research Actually Says If your dog trembles during thunderstorms, destroys furniture when you...
Read moreAffiliate Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.
As research into CBD expands, scientists are investigating its role in immune system support. Early findings suggest CBD may help modulate immune response, potentially benefiting dogs prone to infections or with compromised immunity.
CBD doesn’t boost immunity directly. Instead, it helps regulate immune response, ensuring it’s neither over-active (causing inflammation) nor under-active (failing to protect).
Chronic stress suppresses immune function. By reducing anxiety, CBD indirectly supports a stronger immune response.
Chronic inflammation exhausts the immune system. CBD’s anti-inflammatory properties allow immune energy to focus on protection rather than fighting inflammation.
In vitro studies demonstrate CBD’s interaction with immune cells, suggesting potential for enhancing beneficial immune responses. However, animal and human trials are limited.
Dog owners report that CBD-using pets seem to recover faster from minor illnesses and show fewer secondary infections. While anecdotal, these observations suggest immune benefits.
Immune support isn’t achieved with high doses. Instead, consistent, moderate dosing seems optimal: 1-3mg CBD per pound of body weight daily. Consistency over 4-8 weeks is needed to see immune benefits.
CBD works best as part of a comprehensive immune support plan:
Recent research highlights the gut-immune link. Some evidence suggests CBD supports healthy gut flora, indirectly strengthening immunity. Dogs on CBD often show improved digestive health.
While you can’t directly measure immune function at home, watch for:
CBD is a supportive tool, not a cure-all for immune issues. Work with your vet to address underlying causes of immune compromise while using CBD as a complementary approach.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Pets’ endocannabinoid systems respond to CBD similarly to humans, though with different metabolism and sensitivity thresholds. Research on pet CBD grows yearly, with veterinary schools now researching cannabinoid therapy. While long-term safety studies are ongoing, short-term use shows excellent safety profiles with minimal side effects in most pets.
Start with conservative doses and monitor your pet closely. For anxiety or mild pain: 1-2mg per 10 lbs daily. For moderate issues: 2-5mg per 10 lbs daily. For severe conditions: up to 5mg per 10 lbs with veterinary guidance. Divide daily dose into morning and evening for consistent symptom control. Track dose and response in a log to optimize over time.
Pet-formulated CBD oils are most popular—easy to dose, quick absorption, and adjustable. CBD treats offer convenience for picky eaters. Topical options work best for localized pain or skin issues. Avoid human products with added ingredients, sweeteners, or flavoring that may upset pet digestion. Always verify third-party testing and contact manufacturers with questions about pet formulations.
CBD works synergistically with traditional veterinary care. For pain: combine with appropriate pain medications as approved by your vet. For anxiety: pair with training, desensitization, and calming environment changes. For skin issues: use with appropriate medicated shampoos and allergen avoidance. CBD enhances the effectiveness of comprehensive care plans.

Interested in finding out more about what’s happening in the world of CBD and Medicinal Cannabis?
Head to CBD World News for the latest scientific research, clinical trials, and business news.
Abstract: Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that...
Read moreCredits: Albert Batalla†, Hella Janssen†, Shiral S. Gangadin and Matthijs G. Bossong († These authors contributed equally to this work.)...
Read moreAuthors: Kimberly A. Babson1 & James Sottile 2 & Danielle Morabito1 Publish Date: 27 March 2017 Published by: Springer Science+Business...
Read more